How hospice became big business. A new investigation in The New Yorker reveals an industry that at times puts profits before patients.
The FDA has advised doctors to limit prescriptions of the pain medications Celebrex and Bextra because some data show they may increase the risk of heart attack and stroke. Diane and her guests talk about drug safety, the FDA’s approval process and the agency’s relationship with pharmaceutical companies.
- Gardiner Harris Science reporter for "The New York Times"
- Dr. Paul Antony Chief medical officer for the Pharmaceutical Research and Manufacturers of America
- Dr. Janet Woodcock Deputy commissioner and chief medical officer of the FDA
Most Recent Shows
Pulitzer Prize-winning biographer Jon Meacham on the evolution of Abraham Lincoln's moral principles and political leadership -- and what the era of Lincoln can teach us about the state of our democracy today.
What troubles at Twitter say about the state of social media -- and why one tech watcher argues this could transform the industry in positive ways.
Political analyst Norman Ornstein on control of Congress, the red wave that wasn't, and other lessons from the midterm elections.